Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2009-07-25 00:02:59 UTC |
---|
Update Date | 2022-03-07 02:51:26 UTC |
---|
HMDB ID | HMDB0012563 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 13,14-Dihydro- lipoxin A4 |
---|
Description | 13,14-Dihydro- lipoxin A4 is a lipoxin derivative. Lipoxins (LXs) and aspirin-triggered Lipoxin (ATL) are trihydroxytetraene-containing eicosanoids generated from arachidonic acid that are distinct in structure, formation, and function from the many other proinflammatory lipid-derived mediators. These endogenous eicosanoids have now emerged as founding members of the first class of lipid/chemical mediators involved in the resolution of the inflammatory response. Lipoxin A4 (LXA4), ATL, and their metabolic stable analogs elicit cellular responses and regulate leukocyte trafficking in vivo by activating the specific receptor, ALX. Many of the eicosanoids derived from arachidonic acid (AA2), including prostaglandins (PGs) and leukotrienes (LTs), play important roles as local mediators exerting a wide range of actions relevant in immune hypersensitivity and inflammation. However, recent observations indicate that other agents derived from the lipoxygenase (LO) pathways are formed and play a key role in initiating the resolution of acute inflammation. This phenomenon is an active process that is governed by specific lipid mediators and involves a series of well-orchestrated temporal events. Thus, potent locally released mediators serve as checkpoint controllers of inflammation. In addition to the well-appreciated ability of aspirin to inhibit PGs, aspirin also acetylates cyclooxygenase (COX)-2, triggering the formation of a 15-epimeric form of lipoxins, termed aspirin-triggered LXA4 (ATL). These eicosanoids (i.e., LXA4 and ATL) with a unique trihydroxytetraene structure function as 'stop signals' in inflammation and actively participate in dampening host responses to bring the inflammation to a close, namely, resolution. LXA4 and ATL elicit the multicellular responses via a specific G protein-coupled receptor (GPCR) termed ALX that has been identified in human. (PMID: 16968948 , 11478982 ). |
---|
Structure | CCCCC[C@@H](O)CC\C=C/C=C/C=C/[C@@H](O)[C@H](O)CCCC(O)=O InChI=1S/C20H34O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,10,14,17-19,21-23H,2-3,8-9,11-13,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,14-10+/t17-,18-,19-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(5S,6R,15S)-Trihydroxy-(7E,9E,11Z)-eicosatrienoate | HMDB | (5S,6R,15S)-Trihydroxy-(7E,9E,11Z)-eicosatrienoic acid | HMDB | 13,14-dihydro-LXA(,4) | HMDB |
|
---|
Chemical Formula | C20H34O5 |
---|
Average Molecular Weight | 354.481 |
---|
Monoisotopic Molecular Weight | 354.240624198 |
---|
IUPAC Name | (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11-trienoic acid |
---|
Traditional Name | (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11-trienoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCC[C@@H](O)CC\C=C/C=C/C=C/[C@@H](O)[C@H](O)CCCC(O)=O |
---|
InChI Identifier | InChI=1S/C20H34O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,10,14,17-19,21-23H,2-3,8-9,11-13,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,14-10+/t17-,18-,19-/m1/s1 |
---|
InChI Key | WRFBDEURXXFJRY-WYMHFOEZSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as hydroxyeicosatrienoic acids. These are eicosanoic acids with an attached hydroxyl group and three CC double bonds. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Eicosanoids |
---|
Direct Parent | Hydroxyeicosatrienoic acids |
---|
Alternative Parents | |
---|
Substituents | - Hydroxyeicosatrienoic acid
- Long-chain fatty acid
- Hydroxy fatty acid
- Fatty acid
- Unsaturated fatty acid
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Polyol
- Organic oxide
- Organic oxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organooxygen compound
- Alcohol
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
13,14-Dihydro- lipoxin A4,1TMS,isomer #1 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O)[C@H](O)CCCC(=O)O)O[Si](C)(C)C | 3138.4 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,1TMS,isomer #2 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C)[C@H](O)CCCC(=O)O | 3136.7 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,1TMS,isomer #3 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O)[C@@H](CCCC(=O)O)O[Si](C)(C)C | 3126.4 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,1TMS,isomer #4 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O)[C@H](O)CCCC(=O)O[Si](C)(C)C | 3091.5 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TMS,isomer #1 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C)[C@H](O)CCCC(=O)O)O[Si](C)(C)C | 3135.5 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TMS,isomer #2 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O)[C@@H](CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C | 3126.0 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TMS,isomer #3 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O)[C@H](O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 3102.9 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TMS,isomer #4 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C)[C@@H](CCCC(=O)O)O[Si](C)(C)C | 3152.3 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TMS,isomer #5 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C)[C@H](O)CCCC(=O)O[Si](C)(C)C | 3099.5 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TMS,isomer #6 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O)[C@@H](CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 3094.5 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,3TMS,isomer #1 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C)[C@@H](CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C | 3136.4 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,3TMS,isomer #2 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C)[C@H](O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 3096.4 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,3TMS,isomer #3 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O)[C@@H](CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C | 3082.3 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,3TMS,isomer #4 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C)[C@@H](CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 3120.6 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,4TMS,isomer #1 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C)[C@@H](CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C | 3110.0 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,1TBDMS,isomer #1 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O)[C@H](O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3398.0 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,1TBDMS,isomer #2 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)CCCC(=O)O | 3394.7 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,1TBDMS,isomer #3 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O)[C@@H](CCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3385.0 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,1TBDMS,isomer #4 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O)[C@H](O)CCCC(=O)O[Si](C)(C)C(C)(C)C | 3361.4 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TBDMS,isomer #1 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3626.0 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TBDMS,isomer #2 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O)[C@@H](CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3614.2 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TBDMS,isomer #3 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O)[C@H](O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3606.0 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TBDMS,isomer #4 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](CCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3639.3 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TBDMS,isomer #5 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)CCCC(=O)O[Si](C)(C)C(C)(C)C | 3591.0 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,2TBDMS,isomer #6 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O)[C@@H](CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3588.2 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,3TBDMS,isomer #1 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3899.3 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,3TBDMS,isomer #2 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3861.0 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,3TBDMS,isomer #3 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O)[C@@H](CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3848.9 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,3TBDMS,isomer #4 | CCCCC[C@@H](O)CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3863.1 | Semi standard non polar | 33892256 | 13,14-Dihydro- lipoxin A4,4TBDMS,isomer #1 | CCCCC[C@H](CC/C=C\C=C\C=C\[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4103.3 | Semi standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 13,14-Dihydro- lipoxin A4 GC-MS (Non-derivatized) - 70eV, Positive | splash10-014r-3944000000-5c2b75cf67ef5146bc9c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 13,14-Dihydro- lipoxin A4 GC-MS (4 TMS) - 70eV, Positive | splash10-00b9-6313289000-ae71cdb726adc265eef4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 13,14-Dihydro- lipoxin A4 GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 10V, Positive-QTOF | splash10-00kr-0019000000-6c77b52c82fb0309bb39 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 20V, Positive-QTOF | splash10-00ku-9456000000-5787e1ac9fccd0739dfe | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 40V, Positive-QTOF | splash10-0006-9330000000-801cc2c10d467dfc03ed | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 10V, Negative-QTOF | splash10-0udi-0009000000-0d49f4b58ebb31b682df | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 20V, Negative-QTOF | splash10-000i-4379000000-9766432761c6dd2738e9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 40V, Negative-QTOF | splash10-0a4i-9340000000-669904acdb57de8f8aeb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 10V, Positive-QTOF | splash10-014r-0119000000-fa2fb724fbc2943a8eb7 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 20V, Positive-QTOF | splash10-014r-1739000000-7885143353316f514d46 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 40V, Positive-QTOF | splash10-00r6-9400000000-1032bdd6cb9a1074205d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 10V, Negative-QTOF | splash10-0udr-0009000000-0a1436f9efc7e2aab2d6 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 20V, Negative-QTOF | splash10-0fri-4349000000-62c84297c96217a0441e | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13,14-Dihydro- lipoxin A4 40V, Negative-QTOF | splash10-066v-9320000000-4a445e2526a91ccd3c88 | 2021-09-23 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB029129 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 30776635 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 53481469 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - McMahon B, Mitchell S, Brady HR, Godson C: Lipoxins: revelations on resolution. Trends Pharmacol Sci. 2001 Aug;22(8):391-5. [PubMed:11478982 ]
- Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C: The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev. 2006 Sep;58(3):463-87. [PubMed:16968948 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|